Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells
No hay miniatura disponible
Archivos
Fecha
2023-02
Profesor/a Guía
Facultad/escuela
Idioma
en
Título de la revista
ISSN de la revista
Título del volumen
Editor
MDPI
Nombre de Curso
Licencia CC
CC BY 4.0 Attribution 4.0 International Deed
Licencia CC
https://creativecommons.org/licenses/by/4.0/
Resumen
Glioblastoma (GBM) is the most common and aggressive type of brain tumor due to its elevated recurrence following treatments. This is mainly mediated by a subpopulation of cells with stemness traits termed glioblastoma stem-like cells (GSCs), which are extremely resistant to anti-neoplastic drugs. Thus, an advancement in the understanding of the molecular processes underlying GSC occurrence should contribute significantly towards progress in reducing aggressiveness. High levels of endothelin-converting enzyme-1 (ECE1), key for endothelin-1 (ET-1) peptide activation, have been linked to the malignant progression of GBM. There are four known isoforms of ECE1 that activate ET-1, which only differ in their cytoplasmic N-terminal sequences. Isoform ECE1c is phosphorylated at Ser-18 and Ser-20 by protein kinase CK2, which increases its stability and hence promotes aggressiveness traits in colon cancer cells. In order to study whether ECE1c exerts a malignant effect in GBM, we designed an ECE1c mutant by switching a putative ubiquitination lysine proximal to the phospho-serines Lys-6-to-Arg (i.e., K6R). This ECE1cK6R mutant was stably expressed in U87MG, T98G, and U251 GBM cells, and their behavior was compared to either mock or wild-type ECE1c-expressing clone cells. ECE1cK6R behaved as a highly stable protein in all cell lines, and its expression promoted self-renewal and the enrichment of a stem-like population characterized by enhanced neurospheroid formation, as well as increased expression of stem-like surface markers. These ECE1cK6R-derived GSC-like cells also displayed enhanced resistance to the GBM-related chemotherapy drugs temozolomide and gemcitabine and increased expression of the ABCG2 efflux pump. In addition, ECE1cK6R cells displayed enhanced metastasis-associated traits, such as the modulation of adhesion and the enhancement of cell migration and invasion. In conclusion, the acquisition of a GSC-like phenotype, together with heightened chemoresistance and invasiveness traits, allows us to suggest phospho-ECE1c as a novel marker for poor prognosis as well as a potential therapeutic target for GBM. © 2023 by the authors.
Notas
Indexación: Scopus.
This work was supported by Vicerrectoría de Investigación y Desarrollo de la Universidad de Chile VID ENL10/21 (J.C.T); Líneas de apoyo a la investigación financiadas por el ICBM 2021 (J.C.T.); ANID/BASAL/FB210008 (M.V.G. and V.A.B.); DI-05-20/REG UNAB (V.A.B.); Vicerrectoría de Investigación, Desarrollo y Creación artística (VIDCA) de la Universidad Austral de Chile (C.Q.-M.); ANID/IMII, ICN09-016/ICN 2021-045 (C.Q.-M. and G.I.O.); ANID/FONDAP-ACCDIS 1513001 (G.I.O. and M.V.-G.); and ANID/FONDECYT grants 11220149 (I.N.), 1200049 (L.J.), 1190928 (M.V.G.), 1221033 (F.A.), 1200885 (C.Q.M.), 1220586 (G.I.O.), 3220237 (D.C.-B) and 1220353 (J.C.T.).
This work was supported by Vicerrectoría de Investigación y Desarrollo de la Universidad de Chile VID ENL10/21 (J.C.T); Líneas de apoyo a la investigación financiadas por el ICBM 2021 (J.C.T.); ANID/BASAL/FB210008 (M.V.G. and V.A.B.); DI-05-20/REG UNAB (V.A.B.); Vicerrectoría de Investigación, Desarrollo y Creación artística (VIDCA) de la Universidad Austral de Chile (C.Q.-M.); ANID/IMII, ICN09-016/ICN 2021-045 (C.Q.-M. and G.I.O.); ANID/FONDAP-ACCDIS 1513001 (G.I.O. and M.V.-G.); and ANID/FONDECYT grants 11220149 (I.N.), 1200049 (L.J.), 1190928 (M.V.G.), 1221033 (F.A.), 1200885 (C.Q.M.), 1220586 (G.I.O.), 3220237 (D.C.-B) and 1220353 (J.C.T.).
Palabras clave
Aggressiveness, CK2, Endothelin, Glioblastoma, Stemness
Citación
Cells. Volume 12, Issue 3. February 2023. Article number 506
DOI
10.3390/cells12030506